Related references
Note: Only part of the references are listed.Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes
Manal F. Abdelmalek et al.
HEPATOLOGY (2012)
Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease
S. Petta et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
Vera S. G. Ferreira et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2010)
Hypouricemic Therapy: A Novel Potential Therapeutic Option for Nonalcoholic Fatty Liver Disease
Cheng-Fu Xu et al.
HEPATOLOGY (2010)
The Expression of Aquaporin-1 in the Medulla of the Kidney Is Dependent on the Transcription Factor Associated with Hypertonicity, TonEBP
Miguel A. Lanaspa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice
Julien Bricambert et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Metabolic Effects of Fructose and the Worldwide Increase in Obesity
Luc Tappy et al.
PHYSIOLOGICAL REVIEWS (2010)
High Serum Uric Acid Increases the Risk for Nonalcoholic Fatty Liver Disease: A Prospective Observational Study
Chengfu Xu et al.
PLOS ONE (2010)
Gout and risk of non-alcoholic fatty liver disease
C-F Kuo et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2010)
Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes
Kim-Anne Le et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Replacing dietary glucose with fructose increases ChREBP activity and SREBP-1 protein in rat liver nucleus
Hyun-Young Koo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Relationship between uric acid and hepatic steatosis among Koreans
K. Lee
DIABETES & METABOLISM (2009)
Association Between Serum Uric Acid and Development of Type 2 Diabetes
Satoru Kodama et al.
DIABETES CARE (2009)
Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes?
Richard J. Johnson et al.
ENDOCRINE REVIEWS (2009)
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
Kimber L. Stanhope et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Dietary fructose induces a wide range of genes with distinct shift in carbohydrate and lipid metabolism in fed and fasted rat liver
Hyun-Young Koo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Markedly blunted metabolic effects of fructose in healthy young female subjects compared with male subjects
Caroline Couchepin et al.
DIABETES CARE (2008)
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Xiaosen Ouyang et al.
JOURNAL OF HEPATOLOGY (2008)
Uric acid and cardiovascular risk
Daniel I. Feig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
ChREBP•Mlx is the principal mediator of glucose-induced gene expression in the liver
Lin Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A causal role for uric acid in fructose-induced metabolic syndrome
T Nakagawa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Uric acid-induced C-reactive protein expression: Implication on cell proliferation and nitric oxide production of human vascular cells
DH Kang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver
M Foretz et al.
DIABETES (2005)
Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation
K Masuo et al.
HYPERTENSION (2003)
Contribution of polyol pathway to diabetes-induced oxidative stress
SSM Chung et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2
J Kanellis et al.
HYPERTENSION (2003)
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
RJ Johnson et al.
HYPERTENSION (2003)
Mechanism for fatty acid sparing effect on glucose-induced transcription - Regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase
T Kawaguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Global burden of cardiovascular diseases - Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization
S Yusuf et al.
CIRCULATION (2001)
Share Paper
